Search research articles
Contact Us
Filters
Showing results (111-120 of 158) with videos related to
Page
of 16
Sort By:
Lancet (London, England)
|
September 12, 1987
Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection
A Ranki, S L Valle, M Krohn, et al.
Clinical and Experimental Immunology
|
April 1, 1985
Immune functions in homosexual men with antibodies to HTLV-III in Finland
K Krohn, A Ranki, J Antonen, et al.
The British Journal of Dermatology
|
June 8, 2007
The optimal use of bexarotene in cutaneous T-cell lymphoma
R Gniadecki, C Assaf, M Bagot, et al.
The British Journal of Dermatology
|
August 3, 2006
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
C Assaf, M Bagot, R Dummer, et al.
Archives of Neurology
|
September 1, 1994
Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection
I Elovaara, E Poutiainen, J Lähdevirta, et al.
Lupus
|
April 17, 2008
Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations
S Koskenmies, T M Järvinen, P Onkamo, et al.
AIDS (London, England)
|
December 1, 1992
Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes
B Kohleisen, M Neumann, R Herrmann, et al.
The British Journal of Dermatology
|
September 13, 2006
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
L Dubertret, U Mrowietz, A Ranki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2007
Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?
R Dummer, C Assaf, M Bagot, et al.
Journal of Medical Primatology
|
January 1, 1989
Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings
K Krohn, A Ranki, P Lusso, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 158) with videos related to
Sort By:
Page
of 16
Lancet (London, England)
|
September 12, 1987
Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection
A Ranki, S L Valle, M Krohn, et al.
Clinical and Experimental Immunology
|
April 1, 1985
Immune functions in homosexual men with antibodies to HTLV-III in Finland
K Krohn, A Ranki, J Antonen, et al.
The British Journal of Dermatology
|
June 8, 2007
The optimal use of bexarotene in cutaneous T-cell lymphoma
R Gniadecki, C Assaf, M Bagot, et al.
The British Journal of Dermatology
|
August 3, 2006
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
C Assaf, M Bagot, R Dummer, et al.
Archives of Neurology
|
September 1, 1994
Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection
I Elovaara, E Poutiainen, J Lähdevirta, et al.
Lupus
|
April 17, 2008
Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations
S Koskenmies, T M Järvinen, P Onkamo, et al.
AIDS (London, England)
|
December 1, 1992
Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes
B Kohleisen, M Neumann, R Herrmann, et al.
The British Journal of Dermatology
|
September 13, 2006
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey
L Dubertret, U Mrowietz, A Ranki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 21, 2007
Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?
R Dummer, C Assaf, M Bagot, et al.
Journal of Medical Primatology
|
January 1, 1989
Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings
K Krohn, A Ranki, P Lusso, et al.
Page
of 16